欧美日韩在线二区下载|一区二区粉嫩高清AV|高辣H无码视频在线观看|看AV免费毛片手机播放|91久久丝袜人妻一区二区|国产好痛疼轻点好爽的视频|chinese麻豆自制国产|国产精品亚洲А∨无码播放精品

In 2017, the company plans to achieve an annual sales revenue of 160 million yuan and a profit of 25 million yuan. By 2020, the output value will exceed 50 million yuan and the profit and tax income will reach 80 million yuan. The company makes the greatest contribution to revitalizing the local economy to increase fiscal revenue.

On June 10, 2015, the company was successfully listed on the New Third Board, which laid a solid foundation for the company's next great and rapid development.

In 2014, the company invested 40 million yuan to build the Jiangxi Rainbow Pharmaceutical medical raw material research, production and sale project(The first phase of the project has entered the installation and commissioning phase), to expand the scale of production and expand new fields.

In 2014, the company successfully completed the joint-stock transformation and registered and established Anhui Jinquan Biotechnology Co. Ltd.

In 2012, the company was also recognized by the provincial government as "Provincial Enterprise Technology Center", the company has been awarded "Anhui Private Technology Enterprise", "Anqing Financial trustworthy Enterprise", "Anqing Import and Export advanced Enterprise", "Anqing Wangjiang County Industrial Top Ten Enterprises" and other honors, the company chairman Mr. He Guangquan has been awarded "Excellent entrepreneur" and other titles for many times.

In 2011, the company was identified by the Anqing Municipal People's Government as the "Municipal Enterprise Technology Center", the company was awarded the "Anqing Outstanding Innovative Enterprise".

In 2005, Anhui Jinquan Biotechnology Co., Ltd. (formerly Anqing Jinquan Pharmaceutical Co., Ltd.) was founded in 2005. The company is located in Leichi Industrial Zone in Wangjiang County. The company covers an area of over 80mu with a construction area of 22,000 square meters. The company is a private technological enterprise specializing in production, research and sales.